Interleukin Genetics Presents Research Linking Vertebral Fractures to Gene Variations in Asian Women With Os...(search into the genetic risk for vertebr...),Health

Date:4/1/2009

search into the genetic risk for vertebral fractures," commented Nazneen Aziz, Vice President of Research and Development. "Spinal or vertebral fractures (VF) are a common clinical manifestation of osteoporosis and often lead to serious consequences, including loss of height, severe back pain, and deformity. These new findings should be valuable both in guiding the medical management of osteoporosis by identifying high-risk patients and in the smarter design of clinical drug trials for vertebral fracture treatment."

About Osteoporosis

According to the National Osteoporosis Foundation, osteoporosis is a disease in which bones become fragile and more likely to break. Chronic hyper-inflammation is thought to be an underlying causative factor in osteoporosis. If not prevented or if left untreated, osteoporosis can progress painlessly until a bone breaks. More than 100 million Asian women are estimated to have osteoporosis. The prevalence of osteoporosis is similar between Caucasians and Asian women. The prevalence of osteoporosis in the Japanese female population aged 50 to 79 years is estimated to be about 35 percent. In China, the prevalence of vertebral fracture is about 30 percent for women aged 70 to 79 years, while in India the number of osteoporosis patients was approximately 26 million in 2003, with the numbers projected to increase to 36 million by 2013.

About Interleukin Genetics

Interleukin Genetics, Inc. (NYSE Amex: ILI), is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin Genetics uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin Genetic
'/>"/>

SOURCE Interleukin Genetics, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
2. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
3. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
4. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
5. Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format
6. Interleukin Genetics Wins International Award for Outstanding Research Published in the Journal, Nutrition
7. Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
8. Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. Genetics Determine Optimal Drug Dose of Common Anticoagulant